These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31915653)

  • 1. The increasing trend of blood donation in Iran.
    Taheri Soodejani M; Haghdoost AA; Sedaghat A; Baneshi MR; Zolala F
    Blood Res; 2019 Dec; 54(4):269-273. PubMed ID: 31915653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
    Karimi G; Zadsar M; Pourfathollah AA
    Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of blood transfusion system of iran: 2002-2011.
    Cheraghali A
    Iran J Public Health; 2012; 41(8):89-93. PubMed ID: 23113231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood donation and donor recruitment in Iran from 1998 through 2007: ten years' experience.
    Maghsudlu M; Nasizadeh S; Abolghasemi H; Ahmadyar S
    Transfusion; 2009 Nov; 49(11):2346-51. PubMed ID: 19624488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographical Pattern of Blood Donors and Pre-Donation Deferral Causes in Dhahran, Saudi Arabia.
    Elsafi SH
    J Blood Med; 2020; 11():243-249. PubMed ID: 32765148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between first-year blood donation, return rate for subsequent donation and demographic characteristics.
    Kasraian L; Tavassoli A
    Blood Transfus; 2012 Oct; 10(4):448-52. PubMed ID: 22682334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization.
    Mohammadi S; Aghabozorg F; Balagholi S; Ferdowsi S; Sharifi S; Eshghi P
    Int J Hematol Oncol Stem Cell Res; 2022 Jul; 16(3):151-156. PubMed ID: 36694705
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in Sero-Epidemiology of Human Immunodeficiency Virus in Voluntary Blood Donations in Iran, 2008-2013.
    Zadsar M; Pourfathollah AA; Rasouli M; Karimi G
    Arch Iran Med; 2017 Mar; 20(3):135-140. PubMed ID: 28287806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of COVID-19 on blood safety and availability in the Islamic Republic of Iran.
    Divkolaye N; Arabkhazaeli A; Hajibeigi B; Eshghi P
    East Mediterr Health J; 2022 Nov; 28(11):823-828. PubMed ID: 36515446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of repeated blood donations on the iron status of male Saudi blood donors.
    Abdullah SM
    Blood Transfus; 2011 Apr; 9(2):167-71. PubMed ID: 21084007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.
    Cheraghali AM; Abolghasemi H
    Haemophilia; 2009 Mar; 15(2):487-93. PubMed ID: 19347989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven Years Trends in Prevalence of Transfusion-Transmissible Viral Infections in Yazd blood Transfusion Organization.
    Javadzadeh Shahshahani H; Vaziri M; Mansouri F
    Iran J Ped Hematol Oncol; 2013; 3(3):119-24. PubMed ID: 24575283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013.
    Keshvari M; Sharafi H; Alavian SM; Mehrabadi H; Zolfaghari S
    Transfus Apher Sci; 2015 Aug; 53(1):38-47. PubMed ID: 25892591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of transfusion-transmissible infection in blood donors in Thammasat University Hospital between 2007-2012.
    Chiamchanya N
    J Med Assoc Thai; 2014 Oct; 97(10):1055-63. PubMed ID: 25632622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of first-time blood donors return behaviour using regression models.
    Kheiri S; Alibeigi Z
    Transfus Med; 2015 Aug; 25(4):243-8. PubMed ID: 25764950
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.